The only way Blarcamesine doesn't get approved is if big money pays off the regulators not to approve it. Blarcamesine is the safest drug in the CNS space proven with over nine years of drug trial results and 58 of the top doctor / scientist approval in peer review. Also preserves brain mass like no other. One capsule a day. That's it. Regulators are approving drugs that have a record of brain bleeding and killing people. This drug should be approved as the SOC drug for Alzheimer disease.
Market Data 
Markets 
AI
